Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Sutherland

Showing results (501-510 of 613) with videos related to

Pageof 62
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 12, 2020
Postnatal Effects of Gestational and Lactational Gavage Exposure to Boric Acid in the Developing Sprague Dawley RatAtLee T D Watson, Vicki L Sutherland, Helen Cunny, et al.
Molecular Cancer Therapeutics|September 21, 2006
A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cellsAlison J Butt, Caroline G Roberts, Alan A Seawright, et al.
Toxicologic Pathology|May 29, 2016
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug DevelopmentWendy G Halpern, Mehrdad Ameri, Christopher J Bowman, et al.
Molecular and Cellular Biology|November 21, 2012
TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancersBenjamin J Shields, Florian Wiede, Esteban N Gurzov, et al.
BJU International|November 8, 2007
The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levelsGianluca Severi, Vanessa M Hayes, Andrea A Tesoriero, et al.
Journal of Physical Activity & Health|September 12, 2020
Implementation of a School Physical Activity Policy Improves Student Physical Activity Levels: Outcomes of a Cluster-Randomized Controlled TrialNicole K Nathan, Rachel L Sutherland, Kirsty Hope, et al.
British Journal of Cancer|December 11, 2008
BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastE K A Millar, L R Anderson, C M McNeil, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
Cancer Research|September 24, 2009
Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profilingLiangli Zhao, Brian Y Lee, David A Brown, et al.
Breast Cancer Research : BCR|November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXAlan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Pageof 62

Showing results (501-510 of 613) with videos related to

Sort By:
Pageof 62
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 12, 2020
Postnatal Effects of Gestational and Lactational Gavage Exposure to Boric Acid in the Developing Sprague Dawley RatAtLee T D Watson, Vicki L Sutherland, Helen Cunny, et al.
Molecular Cancer Therapeutics|September 21, 2006
A novel plant toxin, persin, with in vivo activity in the mammary gland, induces Bim-dependent apoptosis in human breast cancer cellsAlison J Butt, Caroline G Roberts, Alan A Seawright, et al.
Toxicologic Pathology|May 29, 2016
Scientific and Regulatory Policy Committee Points to Consider Review: Inclusion of Reproductive and Pathology End Points for Assessment of Reproductive and Developmental Toxicity in Pharmaceutical Drug DevelopmentWendy G Halpern, Mehrdad Ameri, Christopher J Bowman, et al.
Molecular and Cellular Biology|November 21, 2012
TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancersBenjamin J Shields, Florian Wiede, Esteban N Gurzov, et al.
BJU International|November 8, 2007
The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levelsGianluca Severi, Vanessa M Hayes, Andrea A Tesoriero, et al.
Journal of Physical Activity & Health|September 12, 2020
Implementation of a School Physical Activity Policy Improves Student Physical Activity Levels: Outcomes of a Cluster-Randomized Controlled TrialNicole K Nathan, Rachel L Sutherland, Kirsty Hope, et al.
British Journal of Cancer|December 11, 2008
BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastE K A Millar, L R Anderson, C M McNeil, et al.
Molecular and Cellular Endocrinology|December 23, 2008
HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancerKrishan K Rasiah, Margaret Gardiner-Garden, Emma J D Padilla, et al.
Cancer Research|September 24, 2009
Identification of candidate biomarkers of therapeutic response to docetaxel by proteomic profilingLiangli Zhao, Brian Y Lee, David A Brown, et al.
Breast Cancer Research : BCR|November 7, 2012
Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IXAlan S Coates, Ewan K A Millar, Sandra A O'Toole, et al.
Pageof 62